Development, optimization and pharmacokinetic evaluation of biphasic extended-release osmotic drug delivery system of trospium chloride for promising application in treatment of overactive bladder

被引：0
|
作者：
Ramakanth Gundu
Sanjay Pekamwar
Santosh Shelke
Deepak Kulkarni
Santosh Shep
机构：
[1] Swami Ramanand Teerth Marathwada University,School of Pharmacy
[2] Srinath College of Pharmacy,undefined
[3] Shenfadu Fakirba Sonawane Institute of Pharmacy,undefined
来源：
Future Journal of Pharmaceutical Sciences | / 7卷
关键词：
Trospium chloride; Push–pull osmotic pump; Drug release; Pharmacokinetic; Overactive bladder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 30 条
  • [1] Development, optimization and pharmacokinetic evaluation of biphasic extended-release osmotic drug delivery system of trospium chloride for promising application in treatment of overactive bladder
    Gundu, Ramakanth
    Pekamwar, Sanjay
    Shelke, Santosh
    Kulkarni, Deepak
    Shep, Santosh
    [J]. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)
  • [2] Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder
    Dmochowski, Roger R.
    Rosenberg, Matt T.
    Zinner, Norm R.
    Staskin, David R.
    Sand, Peter K.
    [J]. VALUE IN HEALTH, 2010, 13 (02) : 251 - 257
  • [3] Safety and Efficacy of Once-Daily Trospium Chloride Extended-release in Male Patients With Overactive Bladder
    MacDiarmid, Scott A.
    Ellsworth, Pamela I.
    Ginsberg, David A.
    Oefelein, Michael G.
    Sussman, David O.
    [J]. UROLOGY, 2011, 77 (01) : 24 - 29
  • [4] An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder
    Goldenberg, MM
    [J]. CLINICAL THERAPEUTICS, 1999, 21 (04) : 634 - 642
  • [5] Study of the Population Pharmacokinetic Characteristics of Once-Daily Trospium Chloride 60 mg Extended-Release Capsules in Patients with Overactive Bladder and in Healthy Subjects
    Mark D. Harnett
    James Shipley
    Laura MacLean
    Ute Schwiderski
    Bobby W. Sandage
    [J]. Clinical Drug Investigation, 2013, 33 : 133 - 141
  • [6] Study of the Population Pharmacokinetic Characteristics of Once-Daily Trospium Chloride 60 mg Extended-Release Capsules in Patients with Overactive Bladder and in Healthy Subjects
    Harnett, Mark D.
    Shipley, James
    MacLean, Laura
    Schwiderski, Ute
    Sandage, Bobby W., Jr.
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 (02) : 133 - 141
  • [7] Once-Daily Trospium Chloride 60 mg Extended-Release Provides Effective, Long-Term Relief of Overactive Bladder Syndrome Symptoms
    Zinner, Norman R.
    Dmochowski, Roger R.
    Staskin, David R.
    Siami, Paul F.
    Sand, Peter K.
    Oefelein, Michael G.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2011, 30 (07) : 1214 - 1219
  • [8] Formulation and Development of Extended-Release Micro Particulate Drug Delivery System of Solubilized Rifaximin
    Rohan V. Karanje
    Yogita V. Bhavsar
    Kirti H. Jahagirdar
    Kiran S. Bhise
    [J]. AAPS PharmSciTech, 2013, 14 : 639 - 648
  • [9] Formulation and Development of Extended-Release Micro Particulate Drug Delivery System of Solubilized Rifaximin
    Karanje, Rohan V.
    Bhavsar, Yogita V.
    Jahagirdar, Kirti H.
    Bhise, Kiran S.
    [J]. AAPS PHARMSCITECH, 2013, 14 (02): : 639 - 648
  • [10] Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: Results of the OBJECT study
    Appell, RA
    Sand, P
    Dmochowski, R
    Anderson, R
    Zinner, N
    Lama, D
    Roach, M
    Miklos, J
    Saltzstein, D
    Boone, T
    Staskin, DR
    Albrecht, D
    [J]. MAYO CLINIC PROCEEDINGS, 2001, 76 (04) : 358 - 363
123